Neumora Therapeutics is trading at $0.50, up 6.38% in after-hours trading; no company-specific cause for the move was established.

  • The regular-session close was $0.47 on October 19; the after-hours price and percentage are from the supplied price context.
  • Technology sentiment rebounded on October 19 as investors returned to chip and AI-related stocks after the prior sell-off. This offers possible market context, not a confirmed direct cause for Neumora Therapeutics’ move.